Pub 100-03 Medicare National Coverage Determinations: Percutaneous Transluminal Angioplasty of the Carotid Artery Concurrent With Stenting
Guidance that announces CMS has decided to make no change to the national coverage determination (NCD) for percutaneous transluminal angioplasty (PTA) of the carotid artery concurrent with stenting (CAS). This is the result of a request CMS received to its revise policy on CAS to cover patients at high risk for carotid endarterectomy (CEA) due to defined anatomic factors, and who have either symptomatic carotid artery stenosis of 50-69% (or greater) or asymptomatic carotid artery stenosis of greater then 80%.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 24, 2008
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.